Prospects for the Application of Transplantation With Human Amniotic Membrane Epithelial Stem Cells in Systemic Lupus Erythematosus
- PMID: 38469823
- PMCID: PMC10935745
- DOI: 10.1177/09636897241236586
Prospects for the Application of Transplantation With Human Amniotic Membrane Epithelial Stem Cells in Systemic Lupus Erythematosus
Abstract
Systemic lupus erythematosus (SLE) is a multi-organ and systemic autoimmune disease characterized by an imbalance of humoral and cellular immunity. The efficacy and side effects of traditional glucocorticoid and immunosuppressant therapy remain controversial. Recent studies have revealed abnormalities in mesenchymal stem cells (MSCs) in SLE, leading to the application of bone marrow-derived MSCs (BM-MSCs) transplantation technique for SLE treatment. However, autologous transplantation using BM-MSCs from SLE patients has shown suboptimal efficacy due to their dysfunction, while allogeneic mesenchymal stem cell transplantation (MSCT) still faces challenges, such as donor degeneration, genetic instability, and immune rejection. Therefore, exploring new sources of stem cells is crucial for overcoming these limitations in clinical applications. Human amniotic epithelial stem cells (hAESCs), derived from the eighth-day blastocyst, possess strong characteristics including good differentiation potential, immune tolerance with low antigen-presenting ability, and unique immune properties. Hence, hAESCs hold great promise for the treatment of not only SLE but also other autoimmune diseases.
Keywords: human amniotic epithelial stem cells; systemic lupus erythematosus; transplantation.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
Hematopoietic and mesenchymal stem cell transplantation for severe and refractory systemic lupus erythematosus.Clin Immunol. 2013 Aug;148(2):186-97. doi: 10.1016/j.clim.2013.05.014. Epub 2013 May 30. Clin Immunol. 2013. PMID: 23770628 Review.
-
Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.Lupus. 2015 Oct;24(11):1221-6. doi: 10.1177/0961203315583541. Epub 2015 Apr 24. Lupus. 2015. PMID: 25914407
-
Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors' Repertoire in the Recovery of Systemic Lupus Erythematosus.Stem Cell Rev Rep. 2023 Feb;19(2):322-344. doi: 10.1007/s12015-022-10452-7. Epub 2022 Oct 22. Stem Cell Rev Rep. 2023. PMID: 36272020 Review.
-
Safety and tolerability of bone marrow-derived mesenchymal stem cells in lupus animal models and a phase I clinical trial in humans.Lupus. 2022 Sep;31(10):1245-1253. doi: 10.1177/09612033221111957. Epub 2022 Jul 8. Lupus. 2022. PMID: 35802867 Clinical Trial.
-
Therapeutic Applications of Mesenchymal Stem Cells for Systemic Lupus Erythematosus.Adv Exp Med Biol. 2018;1089:73-85. doi: 10.1007/5584_2018_212. Adv Exp Med Biol. 2018. PMID: 29767288 Review.
References
-
- Nie Y, Lau C, Lie A, Chan GC, Mok MY. Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus. 2010;19(7):850–59. - PubMed
-
- Li X, Liu L, Meng D, Wang D, Zhang J, Shi D, Liu H, Xu H, Lu L, Sun L. Enhanced apoptosis and senescence of bone-marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Stem Cells. 2012;21(13):2387–94. - PubMed
-
- Gu Z, Tan W, Feng G, Meng Y, Shen B, Liu H, Cheng C. Wnt / beta-catenin signaling mediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53 / p21 path- way. Mol Cell Biochem. 2014;387(1–2):27–37. - PubMed
-
- Feng X, Che N, Liu Y, Chen H, Wang D, Li X, Chen W, Ma X, Hua B, Gao X, Tsao BP, et al.. Restored immunosuppressive effect of mesenchymal stem cells on B cells after olfactory 1 / early B cell factor-associated zinc-finger protein down-regulation in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2014;66(12):3413–23. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical